L’Oréal links GLP-1 use to changing beauty and skincare demand
L’Oréal CEO Nicolas Hieronimus said on an investor call that the growing use of GLP-1 weight-loss drugs was affecting beauty consumption, particularly skincare. He described the trend as a “very important phenomenon” for the company and said L’Oréal brands…
